| 1 |
Zoetis Inc. |
ZTS |
95.6 |
+8.0% |
+14.1% |
+20.5% |
| 2 |
ABBOTT LABORATORIES |
ABT |
73.6 |
+7.7% |
+30.5% |
+11.7% |
| 3 |
Merck & Co., Inc. |
MRK |
73.34 |
+6.8% |
+9.7% |
+6.0% |
| 4 |
AbbVie Inc. |
ABBV |
70.65 |
+10.9% |
-1.9% |
+14.2% |
| 5 |
ELI LILLY & Co |
LLY |
70.47 |
+12.2% |
n/a |
+11.3% |
| 6 |
JOHNSON & JOHNSON |
JNJ |
69.32 |
+2.2% |
+17.1% |
+4.2% |
| 7 |
BRISTOL MYERS SQUIBB CO |
BMY |
62.69 |
+12.4% |
n/a |
+9.7% |
| 8 |
CORCEPT THERAPEUTICS INC |
CORT |
62.05 |
+23.1% |
+16.5% |
n/a |
| 9 |
PHIBRO ANIMAL HEALTH CORP |
PAHC |
59.32 |
+5.1% |
-17.2% |
+2.7% |
| 10 |
ACADIA PHARMACEUTICALS INC |
ACAD |
57.35 |
+42.7% |
n/a |
n/a |
| 11 |
PERRIGO Co plc |
PRGO |
57.31 |
-1.5% |
n/a |
+7.5% |
| 12 |
VERTEX PHARMACEUTICALS INC |
VRTX |
56.76 |
+24.7% |
n/a |
n/a |
| 13 |
BIOMARIN PHARMACEUTICAL INC |
BMRN |
56.5 |
+11.5% |
n/a |
n/a |
| 14 |
PFIZER INC |
PFE |
56.38 |
+5.0% |
-6.8% |
+3.2% |
| 15 |
Jazz Pharmaceuticals plc |
JAZZ |
54.55 |
+13.8% |
n/a |
n/a |
| 16 |
REGENERON PHARMACEUTICALS, INC. |
REGN |
53.43 |
+15.0% |
+19.3% |
n/a |
| 17 |
Sarepta Therapeutics, Inc. |
SRPT |
52.36 |
+64.0% |
n/a |
n/a |
| 18 |
COLLEGIUM PHARMACEUTICAL, INC |
COLL |
52.28 |
+63.9% |
n/a |
n/a |
| 19 |
Pacira BioSciences, Inc. |
PCRX |
51.72 |
+12.9% |
n/a |
n/a |
| 20 |
HARROW, INC. |
HROW |
51.36 |
+31.6% |
n/a |
n/a |
| 21 |
Ultragenyx Pharmaceutical Inc. |
RARE |
50.72 |
+118.6% |
n/a |
n/a |
| 22 |
ALNYLAM PHARMACEUTICALS, INC. |
ALNY |
49.92 |
+65.4% |
n/a |
n/a |
| 23 |
UNITED THERAPEUTICS Corp |
UTHR |
49.58 |
+7.9% |
n/a |
n/a |
| 24 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
49.25 |
+14.7% |
n/a |
n/a |
| 25 |
AYTU BIOPHARMA, INC |
AYTU |
48.44 |
+58.4% |
n/a |
n/a |
| 26 |
SUPERNUS PHARMACEUTICALS, INC. |
SUPN |
48.16 |
+12.9% |
n/a |
n/a |
| 27 |
HERON THERAPEUTICS, INC. |
HRTX |
46.57 |
+40.0% |
n/a |
n/a |
| 28 |
Organogenesis Holdings Inc. |
ORGO |
46.53 |
+16.2% |
n/a |
n/a |
| 29 |
ANI PHARMACEUTICALS INC |
ANIP |
46.43 |
+21.2% |
n/a |
n/a |
| 30 |
PTC THERAPEUTICS, INC. |
PTCT |
44.97 |
+32.5% |
n/a |
n/a |
| 31 |
Elanco Animal Health Inc |
ELAN |
44.76 |
+6.7% |
n/a |
n/a |
| 32 |
Alkermes plc. |
ALKS |
44.2 |
+7.6% |
n/a |
n/a |
| 33 |
Bausch Health Companies Inc. |
BHC |
43.77 |
+0.8% |
n/a |
n/a |
| 34 |
BeOne Medicines Ltd. |
ONC |
43.71 |
+99.0% |
n/a |
n/a |
| 35 |
RIGEL PHARMACEUTICALS INC |
RIGL |
43.6 |
+41.4% |
n/a |
n/a |
| 36 |
Amneal Pharmaceuticals, Inc. |
AMRX |
43.04 |
+12.6% |
n/a |
n/a |
| 37 |
NATURES SUNSHINE PRODUCTS INC |
NATR |
42.76 |
+4.1% |
n/a |
n/a |
| 38 |
Vanda Pharmaceuticals Inc. |
VNDA |
42.59 |
+3.2% |
n/a |
n/a |
| 39 |
Prestige Consumer Healthcare Inc. |
PBH |
41.96 |
+2.4% |
n/a |
n/a |
| 40 |
Arbutus Biopharma Corp |
ABUS |
41.76 |
+18.5% |
n/a |
n/a |
| 41 |
MANNKIND CORP |
MNKD |
41.45 |
+27.4% |
n/a |
n/a |
| 42 |
Karyopharm Therapeutics Inc. |
KPTI |
41.36 |
+89.9% |
n/a |
n/a |
| 43 |
Lifevantage Corp |
LFVN |
41.2 |
+0.5% |
+1.2% |
n/a |
| 44 |
OCULAR THERAPEUTIX, INC |
OCUL |
41.04 |
+62.1% |
n/a |
n/a |
| 45 |
Lexaria Bioscience Corp. |
LEXX |
40.85 |
+25.4% |
n/a |
n/a |
| 46 |
IONIS PHARMACEUTICALS INC |
IONS |
40.61 |
+6.7% |
n/a |
n/a |
| 47 |
LIGAND PHARMACEUTICALS INC |
LGND |
40.59 |
+4.9% |
n/a |
n/a |
| 48 |
Cryoport, Inc. |
CYRX |
40.22 |
+47.2% |
n/a |
n/a |
| 49 |
ROCKWELL MEDICAL, INC. |
RMTI |
39.84 |
+5.1% |
n/a |
n/a |
| 50 |
STANDARD BIOTOOLS INC. |
LAB |
38.64 |
-2.1% |
n/a |
n/a |
| 51 |
Fortress Biotech, Inc. |
FBIO |
38.62 |
+7.7% |
n/a |
n/a |
| 52 |
Akebia Therapeutics, Inc. |
AKBA |
38.61 |
+30.1% |
n/a |
n/a |
| 53 |
Innoviva, Inc. |
INVA |
38.58 |
+9.8% |
-1.2% |
n/a |
| 54 |
CUMBERLAND PHARMACEUTICALS INC |
CPIX |
38.33 |
+2.6% |
n/a |
n/a |
| 55 |
AMARIN CORP PLC\UK |
AMRN |
37.51 |
+4.4% |
n/a |
n/a |
| 56 |
Jaguar Health, Inc. |
JAGX |
36.95 |
+36.9% |
n/a |
n/a |
| 57 |
Travere Therapeutics, Inc. |
TVTX |
36.82 |
+7.6% |
n/a |
n/a |
| 58 |
CytomX Therapeutics, Inc. |
CTMX |
36.17 |
+15.2% |
n/a |
n/a |
| 59 |
Spero Therapeutics, Inc. |
SPRO |
36.13 |
+72.8% |
n/a |
n/a |
| 60 |
Emergent BioSolutions Inc. |
EBS |
36.07 |
+6.1% |
n/a |
n/a |
| 61 |
Cartesian Therapeutics, Inc. |
RNAC |
35.83 |
+38.7% |
n/a |
n/a |
| 62 |
SIGA TECHNOLOGIES INC |
SIGA |
35.56 |
+21.2% |
n/a |
n/a |
| 63 |
Wave Life Sciences Ltd. |
WVE |
35.34 |
+43.9% |
n/a |
n/a |
| 64 |
TG THERAPEUTICS, INC. |
TGTX |
34.62 |
+193.6% |
n/a |
n/a |
| 65 |
MACROGENICS INC |
MGNX |
34.06 |
+3.8% |
n/a |
n/a |
| 66 |
Theravance Biopharma, Inc. |
TBPH |
34.06 |
+9.9% |
n/a |
n/a |
| 67 |
PROTHENA CORP PUBLIC LTD CO |
PRTA |
33.5 |
+54.6% |
n/a |
n/a |
| 68 |
IRONWOOD PHARMACEUTICALS INC |
IRWD |
33.38 |
+1.8% |
n/a |
n/a |
| 69 |
LIFECORE BIOMEDICAL, INC. \DE\ |
LFCR |
33.31 |
-19.7% |
n/a |
n/a |
| 70 |
TherapeuticsMD, Inc. |
TXMD |
32.33 |
-24.9% |
n/a |
n/a |
| 71 |
ANAPTYSBIO, INC |
ANAB |
31.17 |
+32.2% |
n/a |
n/a |
| 72 |
ARROWHEAD PHARMACEUTICALS, INC. |
ARWR |
31.17 |
+59.3% |
n/a |
n/a |
| 73 |
NEKTAR THERAPEUTICS |
NKTR |
30.47 |
-17.5% |
n/a |
n/a |
| 74 |
IGC Pharma, Inc. |
IGC |
30.27 |
-5.5% |
n/a |
n/a |
| 75 |
LEXICON PHARMACEUTICALS, INC. |
LXRX |
30 |
-30.1% |
n/a |
n/a |
| 76 |
KYNTRA BIO, INC. |
KYNB |
29.3 |
-26.0% |
n/a |
n/a |
| 77 |
Xencor Inc |
XNCR |
28.82 |
+9.9% |
n/a |
n/a |
| 78 |
INOVIO PHARMACEUTICALS, INC. |
INO |
28.74 |
-48.7% |
n/a |
n/a |
| 79 |
PRECIGEN, INC. |
PGEN |
28.13 |
-36.8% |
n/a |
n/a |
| 80 |
VYNE Therapeutics Inc. |
VYNE |
27.7 |
-19.6% |
n/a |
n/a |
| 81 |
Vyome Holdings, Inc |
HIND |
27.67 |
-10.9% |
n/a |
n/a |
| 82 |
CYTOKINETICS INC |
CYTK |
27.49 |
-1.6% |
n/a |
n/a |
| 83 |
OPKO HEALTH, INC. |
OPK |
27.43 |
-5.5% |
n/a |
n/a |
| 84 |
Rafael Holdings, Inc. |
RFL |
26.76 |
-28.1% |
n/a |
n/a |
| 85 |
CHINA PHARMA HOLDINGS, INC. |
CPHI |
25.89 |
-13.1% |
n/a |
n/a |
| 86 |
Traws Pharma, Inc. |
TRAW |
25.53 |
-16.7% |
n/a |
n/a |
| 87 |
ENANTA PHARMACEUTICALS INC |
ENTA |
25.02 |
-7.7% |
n/a |
n/a |
| 88 |
uniQure N.V. |
QURE |
24.98 |
+8.5% |
n/a |
n/a |
| 89 |
Viridian Therapeutics, Inc.\DE |
VRDN |
24.32 |
-5.4% |
n/a |
n/a |
| 90 |
Scienture Holdings, Inc. |
SCNX |
23.34 |
-22.5% |
n/a |
n/a |
| 91 |
Avalo Therapeutics, Inc. |
AVTX |
23 |
-30.3% |
n/a |
n/a |